A 24-year-old woman from Mumbai presents with mucopurulent cervical discharge, dysuria, and lower abdominal pain for 10 days. She had unprotected intercourse 2 weeks ago. On speculum examination, the cervix is inflamed with a mucopurulent exudate. Gram stain of the cervical swab shows no gram-negative diplococci, but nucleic acid amplification test (NAAT) for *Chlamydia trachomatis* is positive. Gonorrhea NAAT is negative. What is the most appropriate treatment?

Explanation

## Diagnosis and Management of Chlamydial Cervicitis ### Clinical Presentation The patient presents with: - Mucopurulent cervical discharge (characteristic of chlamydia) - Dysuria and lower abdominal pain - Absence of gram-negative diplococci on Gram stain (rules out gonorrhea) - **NAAT positive for *Chlamydia trachomatis***, negative for gonorrhea - Incubation period ~2 weeks (longer than gonorrhea's 3–5 days) **Key Point:** *Chlamydia trachomatis* causes 30–50% of non-gonococcal urethritis (NGU) and cervicitis. It is the most common bacterial STI in many developed countries. ### First-Line Treatment for Uncomplicated Chlamydial Infection **High-Yield:** Doxycycline 100 mg orally twice daily for 7 days is the first-line agent for uncomplicated chlamydial urethritis/cervicitis in non-pregnant women [cite:CDC STI Treatment Guidelines 2021; Harrison 21e Ch 163]. ### Why Doxycycline? 1. **Efficacy:** 95–100% cure rate for chlamydia 2. **Resistance:** Extremely rare (chlamydia has no known resistance to tetracyclines) 3. **Cost:** Inexpensive 4. **Tissue penetration:** Excellent intracellular penetration (essential, as chlamydia is obligate intracellular) 5. **Compliance:** Twice-daily dosing for 7 days is standard ### Comparison of Chlamydia Treatment Options | Antibiotic | Dose | Duration | Cure Rate | Resistance | First-Line? | Notes | | --- | --- | --- | --- | --- | --- | --- | | **Doxycycline** | 100 mg BD | 7 days | 95–100% | None | **YES** | Gold standard; excellent intracellular penetration | | Azithromycin | 1 g single | Single dose | 95–98% | Rare | Alternative | Single dose; acceptable but not preferred | | Levofloxacin | 500 mg daily | 5 days | 95–98% | Rare | Alternative | Acceptable; more expensive than doxycycline | | Ceftriaxone | 250 mg IM | Single dose | <50% | — | **NO** | Ineffective for chlamydia; used only for gonorrhea | ### Treatment Algorithm for Cervicitis ```mermaid flowchart TD A[Mucopurulent cervicitis: NAAT results available]:::outcome --> B{Chlamydia positive?}:::decision B -->|Yes, Gonorrhea negative| C[Doxycycline 100 mg BD × 7 days]:::action B -->|Both positive| D[Ceftriaxone 250 mg IM + Doxycycline 100 mg BD × 7]:::action B -->|Chlamydia negative, Gonorrhea positive| E[Ceftriaxone 250 mg IM single dose]:::action C --> F[Counsel: Avoid intercourse × 7 days]:::action D --> F E --> F F --> G[Partner notification and treatment]:::action G --> H[Test of cure: Not routinely needed if compliant]:::outcome ``` ### Important Clinical Considerations **Clinical Pearl:** Although azithromycin (1 g single dose) is an acceptable alternative with similar efficacy, doxycycline remains preferred because: - It is cheaper - Resistance is virtually non-existent - It has better intracellular penetration - Azithromycin is increasingly reserved for macrolide-susceptible gonorrhea co-infections **Warning:** Ceftriaxone is **NOT effective** for chlamydia and should NOT be used as monotherapy. It is only for gonorrhea. The question explicitly states gonorrhea NAAT is negative, so ceftriaxone is unnecessary. **Contraindication in Pregnancy:** Doxycycline is contraindicated in pregnancy (teratogenic). Pregnant women with chlamydia should receive azithromycin 1 g single dose or amoxicillin 500 mg TDS × 7 days. ### Partner Management - All sexual partners from the past 60 days must be notified and treated - Empiric treatment of partners is recommended (do not wait for test results) - Partners should receive the same regimen (doxycycline 100 mg BD × 7 days) ### Test of Cure - **Not routinely recommended** if patient is compliant and symptoms resolve - Repeat NAAT >3 weeks after treatment completion only if symptoms persist or re-exposure is suspected **Mnemonic: DOXY for CHLAMYDIA** — **D**oxycycline, **O**bligatory intracellular, **X**ellent penetration, **Y**early 100% cure, for **C**hlamydia, **H**igh efficacy, **L**ow resistance, **A**lways first-line, **M**ost cost-effective, **Y**ield excellent outcomes, **D**efinitive treatment, **I**ntracellular bacteria, **A**ntibacterial powerhouse.